Activated microglial cells play an important role in inflammatory responses in the central nervous system (CNS) that are involved in
neurodegenerative diseases.
Sauchinone has been shown to modulate the expression of inflammatory factors through
nuclear factor-kappa B (NF-κB) signaling pathway. Here, we examined the effect of
sauchinone on the inflammatory responses of microglia cells induced by
lipopolysaccharide (LPS) and explored the mechanism underlying action of
sauchinone. BV2 cells treated with LPS showed an up-regulation of
nitric oxide (NO) and
prostaglandin (
PGE(2)) release, whereas
sauchinone suppressed this up-regulation.
Sauchinone inhibited both
mRNA and
protein expression of COX-2, iNOS, TNF-α and IL-1β. In addition,
sauchinone blocked the activation of NF-κB through its inhibition of I-κB phosphorylation. Interestingly,
sauchinone had no effect on the LPS-induced phosphorylation of
mitogen activated protein kinases (MAP
kinases; ERK1/2, p38, JNK), but it did inhibit Akt phosphorylation. These results suggest that the inhibitory effect of
sauchinone on the LPS-induced production of inflammatory mediator in BV2 cells is associated with the suppression of the NF-κB and Akt signaling pathways. Therefore,
sauchinone may be a useful treatment for
neurodegenerative disease by inhibiting inflammatory responses in activated microglia.